Business
MedX Health Corp. reaches agreements to settle debts of $362,078
TSX Venture Symbol: MDX    CUSIP #:  585090 MISSISSAUGA, ON, July 4, ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\nTSX Venture Symbol: MDX  \nCUSIP #:  585090\n\n\nMISSISSAUGA, ON, July 4, 2013 /CNW/ - MedX Health Corp. (TSXV - MDX) announces that it has reached agreement with certain creditors to\n settle debts amounting to a total of $362,078 by issuance of 3,620,780\n Units at $0.10 per Unit.  Each Unit comprises one (1) fully paid\n non-assessable common share in the capital of MedX, issued from its\n treasury, and one-half (1/2) of a share purchase warrant.  Each whole\n share purchase warrant entitles the holder to purchase one (1) fully\n paid non-assessable common share from the treasury of MedX during the\n period commencing on the date of issue and expiring on December 31,\n 2015 (the \"Expiration Date\"), at an exercise price of $0.20 if\n exercised before January 1, 2015, and at an exercise price of $0.30 if\n exercised after December 31, 2014 and prior to the Expiration Date. \n These Debt Settlement Agreements are subject to all relevant regulatory\n and other consents and approvals, including in particular, approval of\n the TSX Venture Exchange. Shares comprised in the Units, and shares\n underlying the Warrants comprised in the Units will be subject to\n resale restrictions of four months and one day from the date of\n issuance.  MedX presently has 41,345,511 common shares issued and\n outstanding.\n\n\nAbout MedX Health Corp.\nMedX is a twelve (12) year old Canadian company, headquartered in\n Mississauga, Ontario (Toronto), and is a global leader in the design,\n manufacturing and distribution of quality low level laser and light\n therapy technologies for use in numerous medical settings, including\n rehab/chiropractic, dental, wound care, and veterinary medicine,\n providing patients with drug free and non-invasive treatment of tissue\n damage and pain. MedX laser and light products are FDA approved, Health\n Canada cleared, and CE Mark approved for use in North America as well\n as the European Union. MedX Health acquired the worldwide assets of\n SIMSYS™ and MoleMate™ in June, 2011. For a complete profile of MedX\n Health Corp. and its products visit www.medxhealth.com.\n\n\nAbout SIMSYS™ and MoleMate™ Skin Cancer Imaging \nSIMSYS™ and MoleMate™ received approval from Health Canada, and is\n available for all Canadian physicians and derm...